Site Map Site Map of http://www.researchandmarkets.com - Site Map - Pharmaceuticals and Healthcare    - Pharmaceuticals 1 (Latest Titles)    Pharmaceuticals 2    Pharmaceuticals 3    Pharmaceuticals 4       - Immune Disorders  << You are in This Category #  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z   A Allergic Conjunctivitis: A Specialized Market static version printer friendly Antiviral Drug Licensing Opportunities: Analysis, Rating, and Ranking ... static version printer friendly Antiviral Resistance: Innovation Reshaping Viral Treatment, 2001 Editi... static version printer friendly Autoimmune and Inflammation - Allergy Drug Pipeline Report static version printer friendly pdf version Autoimmune and Inflammation - Arthritis Drug Pipeline Report static version printer friendly pdf version Autoimmune and Inflammation - Autoimmune Diseases Drug Pipeline Report... static version printer friendly pdf version Autoimmune and Inflammation - Crohn Disease Drug Pipeline Report static version printer friendly pdf version Autoimmune and Inflammation - Inflammation - Drug Pipeline Report static version printer friendly pdf version Autoimmune and Inflammation - Lupus Drug Pipeline Report static version printer friendly pdf version Autoimmune and Inflammation - Rheumatoid Arthritis Drug Pipeline Repor... static version printer friendly pdf version Autoimmune and Inflammation - Transplant Rejection or Transplantation ... static version printer friendly pdf version Autoimmune And Inflammation Allergy static version printer friendly pdf version Autoimmune And Inflammation Arthritis  static version printer friendly pdf version Autoimmune And Inflammation Autoimmune Diseases  static version printer friendly pdf version Autoimmune And Inflammation Inflammation  static version printer friendly pdf version Autoimmune And Inflammation Lupus  static version printer friendly pdf version Autoimmune And Inflammation Rheumatoid Arthritis  static version printer friendly pdf version Autoimmune And Inflammation Transplant Rejection or Transplantation  static version printer friendly pdf version Autoimmune Market Outlook to 2012 static version printer friendly pdf version Autoimmune/Inflammatory Disease Drug Licensing Opportunities: Analysis... static version printer friendly Autoimmune/Inflammatory Disease: Competitive Strategies - Competitive ... static version printer friendly ^ Top C Commercial Insight: HIV - Change of Guard static version printer friendly pdf version Commercial Insight: HIV - From the Naïve to the Complex static version printer friendly Countries with the Highest Prevalence of HIV/AIDS static version printer friendly Cytokines, Chemokines, and Growth Factors- Key Targets for Immunothera... static version printer friendly pdf version ^ Top D Disease & Therapy Review (DTR) Executive Market Summaries static version printer friendly pdf version Disease and Therapy Review: Diabetes static version printer friendly pdf version Does the Treatment of Huntingtons Disease Represent a Commercial Oppor... static version printer friendly pdf version Drugs of Tomorrow 2000: Allergic Rhinitis - New Drug Classes, Towards ... static version printer friendly pdf version ^ Top E Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs static version printer friendly pdf version Entry Inhibitors in HIV - An Analysis of a Novel Class static version printer friendly European Autoimmune Diseases Therapeutics Markets static version printer friendly pdf version ^ Top F Food Allergies: Rare but in Need of Risk Assessment static version printer friendly ^ Top H High-tech immunization static version printer friendly HIV - A Way Of Life static version printer friendly HIV - Benchmarking Rapid Antiretroviral Uptake static version printer friendly HIV - Simplicity And Survival static version printer friendly HIV Diagnostics: Key Disease Management Role Spells Opportunity static version printer friendly HIV in South Africa static version printer friendly HIV Update 2001 (2): Midyear Market Analysis and Forecasts static version printer friendly HIV Update 2001 (3) - The impact of resistance testing static version printer friendly HIV Update 2001 (4) - Aids Wasting and Lipodystrophy static version printer friendly HIV Update 2001(1): Focus on Compliance - Once Daily Regimens on the H... static version printer friendly HIV Update 2002 (1) - January static version printer friendly HIV Update 2002 (2) - February static version printer friendly pdf version HIV Update 2002 (3) - March static version printer friendly pdf version HIV Update 2002 (4) - April static version printer friendly HIV Update 2002 (5) - May static version printer friendly pdf version HIV: Future Treatment Directions - A Strategic Analysis of Market Deve... static version printer friendly Human Papilloma Virus - An Oncogenic Pathogen static version printer friendly Human Virology static version printer friendly pdf version ^ Top I Immunomodulators: Therapeutic Needs, Pipelines & Prospects static version printer friendly pdf version Insulin: State-of-the-Science and Strategic Opportunities static version printer friendly pdf version ^ Top M Market Dynamics 2000: Allergic Rhinitis: Effects of Major Patent Expir... static version printer friendly pdf version Monoclonal Antibodies 2007: Competitive Landscape & Pipeline Insight static version printer friendly pdf version ^ Top P Partneringreview 2006: Biopharma Deal Making By Therapy Area - Autoimm... static version printer friendly PharmaVitae 2001: Immunex static version printer friendly PharmaVitae 2001: Medimmune Inc. static version printer friendly Pipeline Insight: HIV - Hold Your Horses static version printer friendly ^ Top R Respiratory Syncytial Virus: Market Entry Opportunites static version printer friendly Rheumatoid arthritis: Emerging drug discovery targets and therapeutic ... static version printer friendly pdf version ^ Top S Selected HIV Drug Prices from International Parallel Importers static version printer friendly Stakeholder Insight: HIV Therapy Dynamics static version printer friendly pdf version Stakeholder Opinions: Systemic Lupus Erythematosus - Market Set to Ent... static version printer friendly pdf version Strategic Perspectives 2001: Dermatological Disorders - A Prototypic M... static version printer friendly Strategic Perspectives 2001: The Antiviral Market - A Market For Expan... static version printer friendly Strategic Perspectives: Opportunistic Infections in HIV static version printer friendly Systemic Lupus Erythematosus: A Route to Other Autoimmune Disease static version printer friendly ^ Top T Target Product Profiles 2008: Physician Insights on Key Attributes - C... static version printer friendly pdf version Target Product Profiles 2008: Physician Insights on Key Attributes - P... static version printer friendly pdf version Target Product Profiles 2008: Physician Insights on Key Attributes - R... static version printer friendly pdf version The 8th Eccath HIV Conference, 2001 static version printer friendly pdf version Thought Leader Insight & Analysis: Psoriasis static version printer friendly pdf version Treatment Algorithms 2001: Allergic Rhinitis - Unlocking the Real Pati... static version printer friendly ^ Top U U.S. Anti-Allergic Therapies Markets static version printer friendly pdf version U.S. HIV Positive Population, 1998-2007 static version printer friendly ^ Top W What Strategies Will Yield Novel Treatments for Autoimmune Disease? static version printer friendly pdf version All rights reserved. © copyright 2008 Research and Markets Terms and conditions Privacy Policy